The commercially available equipment for potentiometric stripping analysis (PSA) was tested for routine lead and cadmium determination in whole-blood samples. In contrast to anodic stripping voltammetry, PSA is not subject to background interferences from organic electroactive constituents in the sample or to the presence of dissolved oxygen (i.e., oxygen removal is not necessary). To determine lead and cadmium by PSA, it is sufficient to dilute the blood sample with an appropriate supporting electrolyte (0.5 mol/L HCI). The detection limit changes with deposition time and volume of blood sample used. For 1 mL of blood and a 1-mm deposition time, the detection limit is 1 zg/L for both elements. If the deposition time increases to 10 mm, cadmium can be determined at its normal concentration in blood (the detection limit is improved to <0.1 g/L). Procedures for routine determination of lead and cadmium in whole blood are presented. in the solution may interfere with the determination by differential pulse ASV, complete digestion of the sample is necessary (3).
pulse mode, is a very sensitive low-cost method that often allows the simulta-in the solution may interfere with the determination by differential pulse ASV, complete digestion of the sample is necessary (3).
The stripping analyzer from ESA (Bedford, MA), which is widely used for clinical purposes (4) (5) (6) (7) , utilizes the staircase stripping mode. The sensitivity of this equipment is not sufficient to determine the low concentrations of cadmium ordinarily present in whole-blood samples (5) . However, lead can be quantified in blood with this instrument even at concentrations <100 .tg/L, but only if one has a human blood standard with lead at 20-30 pg/L (6). A polymer-coated thin mercury film electrode can be used to directly determine lead in whole blood, urine, and sweat, but the sample must be deaerated (8) . PSA is more suitable for trace metal analysis in blood and serum samples (9, 10) .
In this work I tested the commercially available systems of computerized PSA for routine lead and cadmium determinations in whole-blood samples after a simple pretreatment of the sample. 
Materials and Methods

Instrumentation
Procedures
Mercury plating procedure. Every morning the glassycarbon electrode was polished with aluminum oxide powder (0.3-un particles) and rinsed with water. After mixing 10 mL of water and 1 mL of plating solution in the 5-20-mL beaker (Radiometer, code no. 904-488), I set the potential to -3000 mV (vs a saturated standard calomel electrode) and the stirrer to "stir 5." The evolution of hydrogen bubbles on the electrode surface marks the cleaning of electrode surface by this procedure. After a few seconds I turned off the potential, rinsed the electrode with water, and then started the plating procedure. After being plated for 6 mm at different potentials (starting at -300 mV, then decreasing at 1-mm intervals by 100 mV, to end at -800 mV), the electrode surface is covered with a mercury ifim. This film can be used for several analyses (all day or for several days if the potential is maintained over an extended period). Before determining cadmium and lead by ASV, the whole-blood samples are digested with nitric acid in the high-pressure ashing system. I mixed 9.3 mL of water with 0.5 or 1 mL of blood in the standard beaker, then added 0.5 mL of concentrated hydrochloric acid and 0.2 mL of plating solution. Cadmium and lead were deposited at -1150 mV. The deposition time depended on the cadmium concentration. For cadmium concentrations <0.1 .tg/L, the deposition required 10 mm; for concentrations of-i 1.gfL, 1 mm was sufficient. All other steps are similar to those described for the lead determination procedure.
Results and DIscussion Optimization of the Procedure
In stripping techniques three conditions are most important:
deposition potential, deposition time, and sample volume. Figure 1 demonstrates the influence of the deposition potential on the peak area of cadmium and lead in diluted CRM BCR 196 at constant deposition time. The optimal deposition potentials for lead and cadmium determinations, under the described conditions, ranged from -1100 to -1300 mV (vs a saturated standard calomel electrode). At constant deposition potential (-1150 my), the peak area changes with the acid concentration (see Figure 2 ), for two reasons: the liberation of cadmium and lead ions and the evolution of hydrogen. At pH <2, all cadmium and lead ions are electrochemically available. An increase of H concentration increases the amount that can be reduced to form H2 gas. The small hydrogen bubbles destroy the absorption layer of organic substances at the electrode, so the peak areas for cadmium and lead increase. For very high H concentrations or at more negative deposition potentials, the evolution of hydrogen gas on the electrode surface (large H2 bubbles) decreases the electrode surface, so the peak areas for lead and cadmium decrease also.
The lead and cadmium peak areas also change linearly with the blood volume used (Figure 3 ). This is the most important factor for cadmium determinations in whole-blood samples at "normal" concentrations. "Normal" lead concentration in whole-blood samples is <30 g/L (12). For cadmium the "normal" concentration can be <1/300 of the lead concentration (13) . Given these differences, it is very difficult to determine both elements at the same time. For lead determination a sample size of 50 L is adequate; however, handling such a small sample needs an experienced technician, given the risks for contamination or volume errors when transferring the whole-blood samples (the first volume pipetted must be discarded). For cadmium quantification, 0.5 mL of whole blood is necessary.
The third variable that influences peak area is the deposition time. As The concentration of hydrochloric acid is also important in these lead and cadmium determinations (Figure   2 ). At greater pH values (pH >3), the complexing agents in the blood sample (EDTA, proteins, etc.) form complexes with lead and cadmium, so that no oxidation peaks for these elements appear. At low pH values (pH <0.5), the proteins in the sample coagulate; however, this does not substantially influence the results obtained.
As Figure 2 shows, the cadmium and lead peak areas depend very strongly on the pH of the whole-blood sample. At pH <0.6, the cadmium peak area changed with time, probably because of an exchange between free and bound cadmium ions. At pH L5, in all cases (pH <2) the total amount of lead is determined (see data in Table 1 ). From these experimental data it can be concluded that "speciation" of elements could also be carried out by PSA.
The observed change of the peak area with pH affects the sensitivity of the determination for lead. The peak area for lead at pH 0.6 is -=75% greater than at pH 1.5.
For cadmium this change is even more significant. The probable explanation for this phenomenon is the selfcleaning of the electrode surface, which removes adsorbed surfactant.s by hydrogen evolution. for very small sample volumes without a stirrer. In my system, stirring is a condition that can be used to increase the sensitivity. At greater rotational speeds, the amount of reduced elements on the electrode surface increases (the peak area is larger). The optimal stirrer rotation speed for a volume of 10 mL, determined experimentally, is 5-7. At higher stirrer rotations the solution becomes turbulent. Figure 5 demonstrates the influence of Triton X-100 on the peak areas for lead and cadmium determinations in blood. For lead, increasing the Triton X-100 concentration makes no substantial differences in the peak area. For cadmium, a very low concentration of Triton X-iOO greatly reduces the peak area. At higher Triton X-100 concentrations (>10 mLIL), the stirred solution is saturated with air bubbles, which can be adsorbed on the electrode surface. For cadmium determinations in stirred blood samples, the addition of Triton X-i00 is not useful. Given the lack of effect of the time from the collection of the sample to its analysis, lead and cadmium can be determined in fresh whole-blood samples directly after sampling.
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Method Evaluation
Results
of interlaboratory comparison.
Part of the evaluation for the described method involved participation in interlaboratory comparison studies. 
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